Evidence map›Paper›PMID 28714328›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2018

Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia.

Anja Kahl, Corey J Anderson, Liping Qian, Henning Voss, Giovanni Manfredi, Costantino Iadecola, Ping Zhou

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Prohibitin S-Nitrosylation Is Required for the Neuroprotective Effect of Nitric Oxide in Neuronal Cultures.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anja Kahl1 Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, NY, USA.
Corey J Anderson1 Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, NY, USA.
Liping Qian1 Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, NY, USA.
Henning Voss2 Department of Radiology, Weill Cornell Medicine, NY, USA.
Giovanni Manfredi1 Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, NY, USA.
Costantino Iadecola1 Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, NY, USA.
Ping Zhou1 Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, NY, USA.
Weill Cornell Medicine · USCornell University · US

Funding

NO SYNTHASE GENE EXPRESSION AND CEREBRAL ISCHEMIC DAMAGER01NS034179 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IADECOLA, COSTANTINO · 1995 to 2021
$5.5M
ROLE OF PROHIBITIN IN ISCHEMIC BRAIN INJURYR01NS067078 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZHOU, PING · 2009 to 2019
$3.7M
Estrogen receptor beta and mitochondrial permeability transition in Ca2+-induced neuronal injuryR01NS095692 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IADECOLA, COSTANTINO, MANFREDI, GIOVANNI · 2016 to 2020
$1.9M
NINDS NIH HHS R01 NS034179NINDS NIH HHS R01 NS067078NINDS NIH HHS R01 NS095692
6 · The paper itself

Abstract

The mitochondrial protein prohibitin (PHB) has emerged as an important modulator of neuronal survival in different injury modalities . We previously showed that viral gene transfer of PHB protects CA1 neurons from delayed neurodegeneration following transient forebrain ischemia through mitochondrial mechanisms. However, since PHB is present in all cell types, it is not known if its selective expression in neurons is protective, and if the protection occurs also in acute focal ischemic brain injury, the most common stroke type in humans. Therefore, we generated transgenic mice overexpressing human PHB1 specifically in neurons (PHB1 Tg). PHB1 Tg mice and littermate controls were subjected to transient middle cerebral artery occlusion (MCAo). Infarct volume and sensory-motor impairment were assessed three days later. Under the control of a neuronal promoter (CaMKIIα), PHB1 expression was increased by 50% in the forebrain and hippocampus in PHB1 Tg mice. The brain injury produced by MCAo was reduced by 63 ± 11% in PHB1 Tg mice compared to littermate controls. This reduction was associated with improved sensory-motor performance, suggesting that the salvaged brain remains functional. Approaches to enhance PHB expression may be useful to ameliorate the devastating impact of cerebral ischemia on the brain.

Indexed as

Gene Expression RegulationAnimalsBrain IschemiaCalcium-Calmodulin-Dependent Protein Kinase Type 2Disease Models, AnimalHumansMiceMice, TransgenicMitochondrial ProteinsNeuronsNeuroprotective AgentsProhibitinsRepressor ProteinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Mitochondrial ProteinsNeuroprotective AgentsPHB protein, humanProhibitinsRepressor Proteinscerebral blood flowCerebral ischemianeuroprotectionprohibitintransgenic mice

Identifiers

PMID28714328
PMCPMC5999007
OpenAlexW2738408279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.